The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation

Eda K Holl1, Jennifer E Bond, Maria A Selim

  • 1Durham, N.C. From the Departments of Surgery and Pathology, Duke University Medical Center.

Abstract

Insights

Nucleic acids activate fibroblasts and cause scarring. A dendrimer scavenger blocked this activation, reducing wound contraction and improving collagen alignment in a mouse model, offering a potential therapeutic approach for pathologic scarring.

Area of Science:

  • Dermatology and Wound Healing
  • Biomaterials Science
  • Molecular Biology

Background:

  • Pathologic cutaneous scarring is a prevalent global issue with significant economic impact.
  • Understanding fibroblast activation and granulation tissue contraction is crucial for scar prevention.
  • Nucleic acids are hypothesized to drive fibroblast activation and granulation tissue contraction.

Purpose of the Study:

  • To investigate the role of nucleic acids in fibroblast activation and granulation tissue contraction.
  • To evaluate the efficacy of a nucleic acid scavenger dendrimer, polyamidoamine third-generation dendrimer, in mitigating pathologic scarring.

Main Methods:

  • In vitro studies assessed nucleic acid effects on mouse fibroblast cytokine production, migration, and differentiation.
  • Immunofluorescence microscopy evaluated human fibroblast differentiation into myofibroblasts.
  • A murine model assessed the dendrimer's impact on granulation tissue contraction and histology.

Main Results:

  • Nucleic acids increased fibroblast cytokine production, migration, and myofibroblast differentiation.
  • Polyamidoamine third-generation dendrimer inhibited these nucleic acid-induced effects.
  • In vivo, the dendrimer reduced wound contraction, angiogenesis, and altered collagen deposition patterns.

Conclusions:

  • Nucleic acid-stimulated fibroblast activation and granulation tissue contraction are effectively blocked by polyamidoamine third-generation dendrimer.
  • Nucleic acid sequestration presents a promising strategy for preventing pathologic scarring.
  • Targeting pathogen-associated molecular patterns may offer a novel therapeutic avenue for scar management.

Related Concept Videos